Literature DB >> 7320686

Protection against graft vs. host-associated immunosuppression in F1 mice. I. Activation of F1 regulatory cells by host-specific anti-major histocompatibility complex antibodies.

U Hurtenbach, D H Sachs, G M Shearer.   

Abstract

Injection of parental spleen cells into unirradiated F1 hybrid mice results in suppression of the potential to generate cytotoxic T lymphocyte (CTL) responses in vitro. In an attempt to protect the F1 mice from immunosuppression, the recipients were injected with antibodies specific for major histocompatibility complex (MHC)-encoded antigens of the F1 mice 24 h before inoculation of the parental spleen cells. 8-14 d later, the generation of CTL responses in vitro against H-2 alloantigens was tested. Alloantiserum directed against either parental haplotype of the F1 strain markedly diminished the suppression of CTL activity. Furthermore, monoclonal antibodies recognizing H-2 or Ia antigens protected the F2 mice from parental spleen cell-induced suppression. Although this study has been limited to reagents that recognize host H-2 determinants, these findings do not necessarily imply that protection against graft vs. host (GvH) can be achieved only with anti-MHC antibodies. However, protection was observed only by antibodies reactive with F1 antigens, and small amounts of the alloantibodies were sufficient to diminish CTL suppression. Adoptive transfer of spleen cells from syngeneic F1 mice treated with anti-h-2a alloantiserum 24 h previously provided protection equal to that of injection of the recipients with alloantibodies. The cells necessary for this effect were shown to be T cells and to be radiosensitive to 2000 rad. This cell population is induced by antisera against F1 cell surface antigens and effectively counteracts GvH-associated immuno-suppression.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7320686      PMCID: PMC2186549          DOI: 10.1084/jem.154.6.1922

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  22 in total

1.  SYNERGIC AND ANTAGONISTIC EFFECTS OF ISOANTIBODY UPON GRAFT-VERSUS-HOST DISEASE.

Authors:  J R BATCHELOR; J G HOWARD
Journal:  Transplantation       Date:  1965-03       Impact factor: 4.939

Review 2.  The somatic generation of immune recognition.

Authors:  N K Jerne
Journal:  Eur J Immunol       Date:  1971-01       Impact factor: 5.532

Review 3.  Bone-marrow transplantation (first of two parts).

Authors:  E Thomas; R Storb; R A Clift; A Fefer; F L Johnson; P E Neiman; K G Lerner; H Glucksberg; C D Buckner
Journal:  N Engl J Med       Date:  1975-04-17       Impact factor: 91.245

4.  Suppression of the graft-versus-host reaction by passive immunization of donor against recipient antigens.

Authors:  J W Safford; S Tokuda
Journal:  Proc Soc Exp Biol Med       Date:  1970-02

5.  Inhibition of graft-versus-host reactions in mice by host-directed antibody. Effect of serum dose and immunoglobulin subclass.

Authors:  D G Jose; O Stutman; R A Good
Journal:  Transplantation       Date:  1974-02       Impact factor: 4.939

6.  Inhibition of local graft-versus-host reaction by anti-alloantibodies.

Authors:  H Binz; J Lindenmann; H Wigzell
Journal:  Nature       Date:  1973-11-16       Impact factor: 49.962

7.  Anti-receptor antibody and resistance to graft-versus-host disease.

Authors:  T J McKearn; Y Hamada; F P Stuart; F W Fitch
Journal:  Nature       Date:  1974-10-18       Impact factor: 49.962

Review 8.  Cellular immunology and the pathogenesis of graft versus host reactions.

Authors:  W L Elkins
Journal:  Prog Allergy       Date:  1971

9.  Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors.

Authors:  H Glucksberg; R Storb; A Fefer; C D Buckner; P E Neiman; R A Clift; K G Lerner; E D Thomas
Journal:  Transplantation       Date:  1974-10       Impact factor: 4.939

10.  The allogeneic effect in inbred mice. II. Establishment of the cellular interactions required for enhancement of antibody production by the graft-versus-host reaction.

Authors:  D H Katz; D P Osborne
Journal:  J Exp Med       Date:  1972-09-01       Impact factor: 14.307

View more
  2 in total

1.  Transplacental immunization of the human fetus to tetanus by immunization of the mother.

Authors:  T J Gill; C F Repetti; L A Metlay; B S Rabin; F H Taylor; D S Thompson; A L Cortese
Journal:  J Clin Invest       Date:  1983-09       Impact factor: 14.808

2.  Graft-vs.-host-associated immune suppression is activated by recognition of allogeneic murine I-A antigens.

Authors:  G M Shearer; R B Levy
Journal:  J Exp Med       Date:  1983-03-01       Impact factor: 14.307

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.